Cardiovascular Research
The Cardiology department at Metropolitan General Hospital is evaluating new strategies to lower the risk of ischemic stroke in patients with atrial fibrillation who cannot take oral anticoagulants.
- Stroke risk reduction
- Alternative to oral anticoagulation
- Safety and efficacy of novel anticoagulant
This work aims to improve outcomes for high‑risk heart rhythm patients and could expand treatment options beyond traditional blood thinners.
Oncology Research
Researchers are testing a combination of capivasertib and docetaxel in men with metastatic castration‑resistant prostate cancer to see if it extends overall survival and delays disease progression.
- Targeted kinase inhibition
- Chemotherapy synergy
- Survival benefit assessment
The trial reflects Metropolitan General Hospital’s commitment to advancing cancer therapy and offering hope to patients with advanced prostate disease.
